A Novel Marker Affecting Survival in Acute Non-variceal Upper Gastrointestinal Bleeding: Cardiac Troponin I

Yıl: 2021 Cilt: 22 Sayı: 1 Sayfa Aralığı: 38 - 44 Metin Dili: İngilizce DOI: 10.4274/imj.galenos.2020.45403 İndeks Tarihi: 16-06-2021

A Novel Marker Affecting Survival in Acute Non-variceal Upper Gastrointestinal Bleeding: Cardiac Troponin I

Öz:
Introduction: Acute non-variceal upper gastrointestinalbleeding (ANVUGIB) is an important public health problemwith high rates of morbidity and mortality. ANVUGIB resultsin hypovolemia, hypotension, and shock, increasing cardiacoxygen use and may cause elevated serum levels of cardiactroponin (cTn). In this study, we aimed to evaluate whetherelevated cTnI has clinical significance in patients with ANVUGIB.Methods: A total of 62 patients diagnosed with ANVUGIBwhose serum cTnI levels were studied at the time of admissionand follow-up in our clinic from January 2015 to January 2016were included in the study. Patients with acute cardiac diseasesthat may cause elevated cTn were excluded from the study.Results: Forty-three of the patients were male (69.4%), and themean age of all patients was 71.52±13.30 years. The meancTnI level was 0.042±0.097 in all patients, with cTnI levelshigher than the reference value in nine (14.5%) patients. Inlogistic regression analysis, the factors found to contribute tocTnI were tachycardia, chronic kidney disease, and coronaryartery disease. In receiver operating characteristic analysis, cutoff values of 0.025 and 6.5 were found for cTnI and the Rockallscore, respectively. In addition, cTnI and the Rockall score wereshown to affect survival [log-rank (Mantel-Cox) test: p=0.011;log-rank (Mantel-Cox) test: p=0.014; respectively].Conclusion: We believe that serum cTnI levels studied duringthe first admission will be found useful as a biomarker inaddition to the other existing risk determination systems,in order to identify patients at risk, even if findings of acutecoronary syndrome are not observed in patients presentingwith ANVUGIB
Anahtar Kelime:

Akut Varis Dışı Üst Gastrointestinal Kanamada Sağkalımı Etkileyen Yeni Bir Belirteç: Kardiyak Troponin I

Öz:
Amaç: Akut varis dışı üst gastrointestinal sistem kanaması (AVDÜGSK) yüksek mortalite ve morbiditeye sahip önemli bir sağlık sorunudur. AVDÜGSK’leri hipovolemi, hipotansiyon ve şok tablosu oluşturarak kardiyak oksijen kullanımını artırır ve serum kardiyak troponin (kTn) düzeyinin yükselmesine neden olabilir. Biz bu çalışmada AVDÜGSK’si olan hastalarda kTnI yüksekliğinin klinik bir öneme sahip olup olmadığını değerlendirmeyi planladık. Yöntemler: Kliniğimize Ocak 2015-Ocak 2016 tarihleri arasında başvuran, AVDÜGSK tanısı konan, başvuru anında serum kTnI bakılmış olan 62 hasta çalışmaya dahil edildi. kTn yüksekliğine sebep olabilecek akut kardiyak hadisesi olan tüm hastalar çalışma dışı bırakıldı. Bulgular: Çalışmaya alınan hastaların 43’ü erkek (%69,4) olup tüm hastaların ortalama yaşı 71,52±13,30 (25-92) idi. Tüm hastaların ortalama kTnI düzeyi 0,042±0,097 olup 9 (%14,5) hastanın kTnI düzeyi referans aralığının üzerinde idi. Yapılan lojistik regresyon analizinde kTnI düzeyi yüksekliğine katkı yapan faktörler taşikardi, kronik böbrek yetmezliği ve koroner arter hastalığı idi. Yapılan alıcı işletim karakteristiği analizinde kTnI ve rockall skoru için eşik değeri sırasıyla; 0,025 ve 6,5 olarak saptandı ve kTnI ile rockall skorunun yükseliğinin sağkalım üzerinde etkili olduğu gösterildi [sırasıyla; logrank (Mantel-Cox) testi: p=0,011, log-rank (Mantel-Cox) testi: p=0,014]. Sonuç: AVDÜGSK ile başvuran hastalarda akut koroner sendrom bulguları olmasa bile ilk başvuruda serum kTnI düzeyinin bakılmasının riskli hastaların belirlenmesi açısından mevcut diğer risk belirleme yöntem ve skorlama sistemleriyle birlikte, bir biyobelirteç olarak kullanım alanı bulabileceği kanaatindeyiz.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Sey MSL, Mohammed SB, Brahmania M, Singh S, Kahan BC, Jairath V. Comparative outcomes in patients with ulcer‐vs non‐ulcer‐related acute upper gastrointestinal bleeding in the United Kingdom: a nationwide cohort of 4474 patients. Aliment Pharmacol Ther 2019; 49: 537-45.
  • 2. Jairath V, Martel M, Logan RF, Barkun AN. Why do mortality rates for nonvariceal upper gastrointestinal bleeding differ around the world? A systematic review of cohort studies. Can J Gastroenterol 2012; 26: 537-43.
  • 3. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth Universal Definition of Myocardial Infarction. J Am Coll Cardiol 2018; 72: 2231-64.
  • 4. Mair J, Wagner I, Puschendorf B, Mair P, Lechleitner P, Dienstl F, et al. Cardiac troponin I to diagnose myocardial injury. Lancet 1993; 341: 838-9.
  • 5. Korff S, Katus HA, Giannitsis E. Differential diagnosis of elevated troponins. Heart 2006; 92: 987-93.
  • 6. Farber AJ, Suarez K, Slicker K, Patel CD, Pope B, et al. Frequency of Troponin Testing in Inpatient Versus Outpatient Settings. Am J Cardiol 2017; 119: 1153- 5.
  • 7. Alcalai R, Planer D, Culhaoglu A, Osman A, Pollak A, Lotan C. Acute coronary syndrome vs nonspecific troponin elevation: clinical predictors and survival analysis. Arch Intern Med 2007; 167: 276-81.
  • 8. Widmer RJ, Wilson G, Haneke T, Lee M, Fan J, Davis A, et al. Inpatient Mortality and 30-Day Readmission Rates Associated with Troponin Testing in Patients without Acute Myocardial Infarction. Clin Med Res 2020; 18: 82-8.
  • 9. Iser DM, Thompson AJ, Sia KK, Yeomans ND, Chen RY. Prospective study of cardiac troponin I release in patients with upper gastrointestinal bleeding. J Gastroenterol Hepatol 2008; 23: 938-42.
  • 10. Abdalla M, Sohal S, Al-Azzam B, Mohamed W. Effect of Troponin I Elevation on Duration of Mechanical Ventilation and Length of Intensive Care Unit Stay in Patients With Sepsis. J Clin Med Res 2019; 11: 127-32.
  • 11. Ammann P, Maggiorini M, Bertel O, Haenseler E, Joller-Jemelka HI, Oechslin E, et al. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol 2003; 41: 2004-9.
  • 12. Wang N, Li T, Du Q. Risk factors of upper gastrointestinal hemorrhage with acute coronary syndrome. Am J Emerg Med 2019; 37: 615-9.
  • 13. Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet 2000; 356: 1318- 21.
  • 14. Rockall T, Devlin H, Logan R, Northfield T. Selection of patients for early discharge or outpatient care after acute upper gastrointestinal haemorrhage. Lancet 1996; 347: 1138-40.
  • 15. Forrest JH, Finlayson ND, Shearman DJ. Endoscopy in gastrointestinal bleeding. Lancet 1974; 304: 394-7.
  • 16. Gralnek IM, Dumonceau JM, Kuipers EJ, Lanas A, Sanders DS, Kurien M, et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2015; 47: 1-46.
  • 17. Laine L, Jensen DM. Management of patients with ulcer bleeding. Am J Gastroenterol 2012; 107: 345-60.
  • 18. Das A, Wong RC. Prediction of outcome of acute GI hemorrhage: a review of risk scores and predictive models. Gastrointest Endosc 2004; 60: 85-93.
  • 19. Marmo R, Koch M, Cipolletta L, Capurso L, Pera A, Bianco MA, et al. Predictive factors of mortality from nonvariceal upper gastrointestinal hemorrhage: a multicenter study. Am J Gastroenterol 2008; 103: 1639-47.
  • 20. Laursen SB, Dalton HR, Murray IA, Michell N, Johnston MR, Schultz M, et al. Performance of new thresholds of the Glasgow Blatchford score in managing patients with upper gastrointestinal bleeding. Clin Gastroenterol Hepatol 2015; 13: 115-21.
  • 21. Maresca B, Manzione A, Moioli A, Salerno G, Cardelli P, Punzo G, et al. Prognostic value of high-sensitive cardiac troponin I in asymptomatic chronic hemodialysis patients. J Nephrol 2020; 33: 129-36.
  • 22. Artunc F, Haag S, Friedrich B, Mueller C, Häring HU, Peter A. Performance of a novel high sensitivity cardiac troponin I assay in asymptomatic hemodialysis patients - evidence for sex-specific differences. Clin Chem Lab Med 2019; 57: 1261-70.
  • 23. Arlati S, Brenna S, Prencipe L, Marocchi, A, Casella GP, Lanzani M, et al. Myocardial necrosis in ICU patients with acute non-cardiac disease: a prospective study. Intensive Care Med 2000; 26: 31-7.
  • 24. Jendoubi A, Jerbi S, Maamar E, Abbess A, Samoud Z, Kanzari L, at al. Prognostic Value of High-sensitivity Troponin I in Patients with Septic Shock: A Prospective Observational Study. Indian J Crit Care Med 2019; 23: 320-5.
  • 25. Skeik N, Patel DC. A review of troponins in ischemic heart disease and other conditions. Int J Angiol 2007; 16: 53-8.
  • 26. Dauhan AC, Lubis AD, Mutiara E, Lubis M. Correlation of Troponin Level (Troponin T, Troponin I) With PELOD-2 Score in Sepsis as a Predictive Factor of Mortality. Open Access Maced J Med Sci 2019; 7: 4072-7.
  • 27. Klein Gunnewiek JMT, van de Leur JJJPM. Elevated troponin T concentrations in critically ill patients. Intensive Care Med 2003; 29: 2317-22.
  • 28. Hazar A, Cihan HB, Gülcan Ö, Çığlı A, Özyalın F, Türköz R. Perioperatif miyokardiyal hasar tespitinde biyokimyasal belirleyicilerin rolü. Turgut Özal Tıp Merkezi Dergisi 2002; 9: 95-103.
  • 29. Alam A, Palumbo A, Mucsi I, Barré PE, Sniderman AD. Elevated troponin I levels but not low grade chronic inflammation is associated with cardiacspecific mortality in stable hemodialysis patients. BMC Nephrol 2013; 14: 247-54.
  • 30. Noorain S. Prognostic value of cardiac troponin I during acute exacerbation of chronic obstructive pulmonary disease: A prospective study. Lung India 2016; 33: 53-7.
  • 31. Scheitz JF, Nolte CH, Laufs U, Endres M. Application and interpretation of high-sensitivity cardiac troponin assays in patients with acute ischemic stroke. Stroke 2015; 46: 1132-40.
  • 32. Thålin C, Rudberg AS, Johansson F, Jonsson F, Laska AC, Nygren AT, et al. Elevated troponin levels in acute stroke patients predict long-term mortality. J Stroke Cerebrovasc Dis 2015; 24: 2390-6.
  • 33. Lee YJ, Lee H, Park JS, Kim SJ, Cho YJ, Yoon HI, et al. Cardiac troponin I as a prognostic factor in critically ill pneumonia patients in the absence of acute coronary syndrome. J Crit Care 2015; 30: 390-4.
APA Dertli R, biyik m, Yolacan R, Keskin M, KARAKARÇAYILDIZ A, kayar y, Ataseven H, Polat H, Demir A, ASIL M (2021). A Novel Marker Affecting Survival in Acute Non-variceal Upper Gastrointestinal Bleeding: Cardiac Troponin I. , 38 - 44. 10.4274/imj.galenos.2020.45403
Chicago Dertli Ramazan,biyik murat,Yolacan Ramazan,Keskin Muharrem,KARAKARÇAYILDIZ Ahmet,kayar yusuf,Ataseven Huseyin,Polat Hakki,Demir Ali,ASIL MEHMET A Novel Marker Affecting Survival in Acute Non-variceal Upper Gastrointestinal Bleeding: Cardiac Troponin I. (2021): 38 - 44. 10.4274/imj.galenos.2020.45403
MLA Dertli Ramazan,biyik murat,Yolacan Ramazan,Keskin Muharrem,KARAKARÇAYILDIZ Ahmet,kayar yusuf,Ataseven Huseyin,Polat Hakki,Demir Ali,ASIL MEHMET A Novel Marker Affecting Survival in Acute Non-variceal Upper Gastrointestinal Bleeding: Cardiac Troponin I. , 2021, ss.38 - 44. 10.4274/imj.galenos.2020.45403
AMA Dertli R,biyik m,Yolacan R,Keskin M,KARAKARÇAYILDIZ A,kayar y,Ataseven H,Polat H,Demir A,ASIL M A Novel Marker Affecting Survival in Acute Non-variceal Upper Gastrointestinal Bleeding: Cardiac Troponin I. . 2021; 38 - 44. 10.4274/imj.galenos.2020.45403
Vancouver Dertli R,biyik m,Yolacan R,Keskin M,KARAKARÇAYILDIZ A,kayar y,Ataseven H,Polat H,Demir A,ASIL M A Novel Marker Affecting Survival in Acute Non-variceal Upper Gastrointestinal Bleeding: Cardiac Troponin I. . 2021; 38 - 44. 10.4274/imj.galenos.2020.45403
IEEE Dertli R,biyik m,Yolacan R,Keskin M,KARAKARÇAYILDIZ A,kayar y,Ataseven H,Polat H,Demir A,ASIL M "A Novel Marker Affecting Survival in Acute Non-variceal Upper Gastrointestinal Bleeding: Cardiac Troponin I." , ss.38 - 44, 2021. 10.4274/imj.galenos.2020.45403
ISNAD Dertli, Ramazan vd. "A Novel Marker Affecting Survival in Acute Non-variceal Upper Gastrointestinal Bleeding: Cardiac Troponin I". (2021), 38-44. https://doi.org/10.4274/imj.galenos.2020.45403
APA Dertli R, biyik m, Yolacan R, Keskin M, KARAKARÇAYILDIZ A, kayar y, Ataseven H, Polat H, Demir A, ASIL M (2021). A Novel Marker Affecting Survival in Acute Non-variceal Upper Gastrointestinal Bleeding: Cardiac Troponin I. İstanbul Medical Journal, 22(1), 38 - 44. 10.4274/imj.galenos.2020.45403
Chicago Dertli Ramazan,biyik murat,Yolacan Ramazan,Keskin Muharrem,KARAKARÇAYILDIZ Ahmet,kayar yusuf,Ataseven Huseyin,Polat Hakki,Demir Ali,ASIL MEHMET A Novel Marker Affecting Survival in Acute Non-variceal Upper Gastrointestinal Bleeding: Cardiac Troponin I. İstanbul Medical Journal 22, no.1 (2021): 38 - 44. 10.4274/imj.galenos.2020.45403
MLA Dertli Ramazan,biyik murat,Yolacan Ramazan,Keskin Muharrem,KARAKARÇAYILDIZ Ahmet,kayar yusuf,Ataseven Huseyin,Polat Hakki,Demir Ali,ASIL MEHMET A Novel Marker Affecting Survival in Acute Non-variceal Upper Gastrointestinal Bleeding: Cardiac Troponin I. İstanbul Medical Journal, vol.22, no.1, 2021, ss.38 - 44. 10.4274/imj.galenos.2020.45403
AMA Dertli R,biyik m,Yolacan R,Keskin M,KARAKARÇAYILDIZ A,kayar y,Ataseven H,Polat H,Demir A,ASIL M A Novel Marker Affecting Survival in Acute Non-variceal Upper Gastrointestinal Bleeding: Cardiac Troponin I. İstanbul Medical Journal. 2021; 22(1): 38 - 44. 10.4274/imj.galenos.2020.45403
Vancouver Dertli R,biyik m,Yolacan R,Keskin M,KARAKARÇAYILDIZ A,kayar y,Ataseven H,Polat H,Demir A,ASIL M A Novel Marker Affecting Survival in Acute Non-variceal Upper Gastrointestinal Bleeding: Cardiac Troponin I. İstanbul Medical Journal. 2021; 22(1): 38 - 44. 10.4274/imj.galenos.2020.45403
IEEE Dertli R,biyik m,Yolacan R,Keskin M,KARAKARÇAYILDIZ A,kayar y,Ataseven H,Polat H,Demir A,ASIL M "A Novel Marker Affecting Survival in Acute Non-variceal Upper Gastrointestinal Bleeding: Cardiac Troponin I." İstanbul Medical Journal, 22, ss.38 - 44, 2021. 10.4274/imj.galenos.2020.45403
ISNAD Dertli, Ramazan vd. "A Novel Marker Affecting Survival in Acute Non-variceal Upper Gastrointestinal Bleeding: Cardiac Troponin I". İstanbul Medical Journal 22/1 (2021), 38-44. https://doi.org/10.4274/imj.galenos.2020.45403